31 related articles for article (PubMed ID: 17355956)
1. Excellent Outcomes in Children, Adolescents, and Young Adults with Ovarian Germ Cell Tumors Treated by Either Reduced- or Standard-Dose Bleomycin.
Park M; Suh JK; Lee JA; Park HJ; Park EY; Yoo CW; Lim MC; Park SY; Park BK
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958463
[TBL] [Abstract][Full Text] [Related]
2. Overcoming Chemotherapy Resistance in Germ Cell Tumors.
Országhová Z; Kalavska K; Mego M; Chovanec M
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625709
[TBL] [Abstract][Full Text] [Related]
3. Autologous Stem Cell Transplantation in Testicular Germ Cell Tumor-Preliminary Experience from a Single Center.
Selvarajan G; Jayachandran PK; Rajan AK; Kesana S; Kannan K; Sagar TG; Ganesan TS
South Asian J Cancer; 2021 Apr; 10(2):97-101. PubMed ID: 34568223
[No Abstract] [Full Text] [Related]
4. Current Management of Refractory Germ Cell Tumors and Future Directions.
Allen JC; Kirschner A; Scarpato KR; Morgans AK
Curr Oncol Rep; 2017 Feb; 19(2):8. PubMed ID: 28220447
[TBL] [Abstract][Full Text] [Related]
5. Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies.
Reed DR; Mascarenhas L; Manning K; Hale GA; Goldberg J; Gill J; Sandler E; Isakoff MS; Smith T; Caracciolo J; Lush RM; Juan TH; Lee JK; Neuger AM; Sullivan DM
Cancer Med; 2016 Feb; 5(2):294-303. PubMed ID: 26714427
[TBL] [Abstract][Full Text] [Related]
6. Importance of continuous sequential chemotherapy and multimodal treatment for advanced testicular cancer: a high-volume Japanese center experience.
Nakamura T; Ueda T; Oishi M; Nakanishi H; Shiraishi T; Fujihara A; Naito Y; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Medicine (Baltimore); 2015 Mar; 94(11):e653. PubMed ID: 25789960
[TBL] [Abstract][Full Text] [Related]
7. Rapid screening of novel agents for combination therapy in sarcomas.
Cubitt CL; Menth J; Dawson J; Martinez GV; Foroutan P; Morse DL; Bui MM; Letson GD; Sullivan DM; Reed DR
Sarcoma; 2013; 2013():365723. PubMed ID: 24282374
[TBL] [Abstract][Full Text] [Related]
8. Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour.
Rimmer Y; Chester J; Joffe J; Stark D; Shamash J; Powles T; White J; Wason J; Parashar D; Armstrong G; Mazhar D; Williams MV
Br J Cancer; 2011 Sep; 105(6):766-72. PubMed ID: 21847130
[TBL] [Abstract][Full Text] [Related]
9. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.
Hind D; Tappenden P; Tumur I; Eggington S; Sutcliffe P; Ryan A
Health Technol Assess; 2008 May; 12(15):iii-ix, xi-162. PubMed ID: 18462574
[TBL] [Abstract][Full Text] [Related]
10. Current pharmacotherapy for testicular germ cell cancer.
Alsdorf W; Seidel C; Bokemeyer C; Oing C
Expert Opin Pharmacother; 2019 May; 20(7):837-850. PubMed ID: 30849243
[TBL] [Abstract][Full Text] [Related]
11. A phase II study using a topoisomerase I-based approach in patients with multiply relapsed germ-cell tumours.
Shamash J; Powles T; Mutsvangwa K; Wilson P; Ansell W; Walsh E; Berney D; Stebbing J; Oliver T
Ann Oncol; 2007 May; 18(5):925-30. PubMed ID: 17355956
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach.
Badreldin W; Krell J; Chowdhury S; Harland SJ; Mazhar D; Harding V; Frampton AE; Wilson P; Berney D; Stebbing J; Shamash J
BJU Int; 2016 Mar; 117(3):418-23. PubMed ID: 25430674
[TBL] [Abstract][Full Text] [Related]
13. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
14. A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors.
Theodore C; Chevreau C; Yataqhene Y; Fizazi K; Delord JP; Lotz JP; Geoffrois L; Kerbrat P; Bui V; Flechon A
Ann Oncol; 2008 Aug; 19(8):1465-1469. PubMed ID: 18385203
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
